Chronic Lung Allograft Dysfunction MRI Study

Part of paid clinical trials in Iowa City, Iowa.

Sponsor
Sean Fain
Study ID
NCT06406777
Phase
PHASE1/PHASE2
Status
Recruiting

Conditions

  • Chronic Lung Allograft Dysfunction Lung MRI (CLAD)

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Accepted

Interventions

  • Spirometry — DIAGNOSTIC_TEST
    Spirometry measures lung function, specifically the amount and/or speed of air that can be inhaled and exhaled.
  • Contrast Lung Computed Tomography (CT) Scan — DIAGNOSTIC_TEST
    CT scan of the lungs using contrast
  • Oxygen enhanced magnetic resonance imaging (OE-MRI) Scan — DIAGNOSTIC_TEST
    MRI will be taken while subject is lying on their back breathing 100% oxygen.
  • 129Xe MRI scans — DRUG
    MRI will be taken while subject is lying on their back breathing room oxygen and taking a breath of 129Xe and holding it for a few seconds.

Study Details

This studies purpose is to confirm the efficacy and efficiency of using OE-MRI and MRI with hyperpolarized gas techniques and Iodinated contrast CT scan, this will enhance understanding of CLAD pathophysiology. Moreover, this project is foundational to performing additional studies to establish if novel MRI imaging can serve as an objective confirmatory diagnostic tool for CLAD in post-transplant patients.

Key Dates

Start date
Mar 20, 2025
Status verified
Mar 2025
Primary completion
Sep 30, 2028
Completion
Sep 30, 2028

Study Design

Enrollment
100 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Active Comparator: Healthy Normal Subjects
    Healthy subjects, with no lung diagnosis, who are non-smokers.
  • Experimental: Post Lung Transplant with normal functioning
    Subjects who have had a lung transplant and now have normal lung function
  • Experimental: Post Lung Transplant with Chronic Lung Allograft Dysfunction (CLAD)
    Subjects who have had a lung transplant that now have CLAD

Primary Outcome Measure

Forced expiratory volume in 1 second (FEV1) Decline [ Time Frame: Baseline and 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of IowaIowa CityIowa52242
Sean Fail, PhD
319-356-4832

Find similar trials in Iowa City, IA